# Study of TLR9 Agonist Vidutolimod (CMP-001) in Combination With Nivolumab vs. Nivolumab

> clinical trial · VERIFIED · 2026-07-02

Status: COMPLETED · Sponsor: Diwakar Davar · Condition: Melanoma

- Company: Diwakar Davar
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT04401995

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.